Login / Signup

Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients.

David W DodingtonAndrew LagreeSami TabbarahMajid MohebpourAli Sadeghi-NainiWilliam T TranFang-I Lu
Published in: Breast cancer research and treatment (2021)
Analysis of tumor nuclear features using digital pathology/AI can significantly improve models to predict pathological response to NAC.
Keyphrases
  • artificial intelligence
  • neoadjuvant chemotherapy
  • machine learning
  • big data
  • deep learning
  • locally advanced
  • lymph node
  • sentinel lymph node
  • transcription factor
  • squamous cell carcinoma
  • rectal cancer